SEC Form 4 · accession 0001104659-16-125923
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew I Koven
Officer — President & Chief Business Off
Period of report
Jun 3, 2016
Accepted (ET)
Jun 7, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Jun 3, 2016 | F | 206,070 | $3.97 | D | 1,404,236 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This represents shares withheld by the Issuer for payment of withholding tax liability incurred upon the vesting of 369,168 restricted stock units previously granted on June 3, 2015, which vested on June 3, 2016.